BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9558695)

  • 1. Possible involvement of cerebral hypoperfusion as trigger of neurally-mediated vasovagal syncope.
    Abe H; Kohshi K; Kuroiwa A
    Pacing Clin Electrophysiol; 1998 Mar; 21(3):613-6. PubMed ID: 9558695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of neurally mediated syncope induced by laughter successfully treated with combination of propranolol and midodrine.
    Amaki M; Kamide K; Takiuchi S; Niizuma S; Horio T; Kawano Y
    Int Heart J; 2007 Jan; 48(1):123-7. PubMed ID: 17379987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral syncope in a patient with spinal cord injury.
    Bisharat N; Paz E; Klimov A; Friedberg N; Elias M
    Pacing Clin Electrophysiol; 2002 Mar; 25(3):372-3. PubMed ID: 11990670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
    Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
    Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-adrenergic receptor blockers and the treatment of vasovagal syncope: more nails in the coffin!
    Mathias CJ
    Clin Sci (Lond); 2006 Sep; 111(3):189-91. PubMed ID: 16848762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoproterenol Causing Coronary Vasospasm and ST Elevations During Tilt Table Testing.
    Duong H; Masarweh OM; Campbell G; Win TT; Joolhar F
    J Investig Med High Impact Case Rep; 2020; 8():2324709620966862. PubMed ID: 33078637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the effectiveness of beta-blocker therapy in vasovagal syncope.
    Kapoor JR
    J Am Coll Cardiol; 2008 Jun; 51(24):2372; author reply 2372-3. PubMed ID: 18549925
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcome of patients with neurally mediated syncope following tilt table testing.
    Sheldon RS
    Cardiologia; 1997 Aug; 42(8):795-802. PubMed ID: 9286117
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic significance of heart rate in neurally mediated syncope.
    Chan WL; Lu TM; Wang JJ; Jiau SS; Kong CW
    Clin Cardiol; 2004 Nov; 27(11):635-40. PubMed ID: 15562934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of head-up tilt test with intravenous beta-blocker administration in assessing the efficacy of therapy in patients with vasovagal syncope.
    Gielerak G; Makowski K; Cholewa M
    Ann Noninvasive Electrocardiol; 2005 Jan; 10(1):65-72. PubMed ID: 15649240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Relationship of Asystole to Onset of Transient Loss of Consciousness in Tilt-Induced Reflex Syncope.
    Saal DP; Thijs RD; van Zwet EW; Bootsma M; Brignole M; Benditt DG; van Dijk JG
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1592-1598. PubMed ID: 29759842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triggering mechanism for neurally mediated syncope induced by head-up tilt test: role of catecholamines and response to propranolol.
    Kikushima S; Kobayashi Y; Nakagawa H; Katagiri T
    J Am Coll Cardiol; 1999 Feb; 33(2):350-7. PubMed ID: 9973014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in plasma epinephrine concentration and in heart rate during head-up tilt testing in patients with neurocardiogenic syncope: correlation with successful therapy with beta-receptor antagonists.
    Klingenheben T; Kalusche D; Li YG; Schöpperl M; Hohnloser SH
    J Cardiovasc Electrophysiol; 1996 Sep; 7(9):802-8. PubMed ID: 8884509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral vasoconstriction in neurally mediated syncope: relationship with type of head-up tilt test response.
    Silvani S; Padoan G; Guidi AR; Bianchedi G; Maresta A
    Ital Heart J; 2003 Nov; 4(11):768-75. PubMed ID: 14699706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasovagal syncope: new physiologic insights.
    Jardine DL
    Cardiol Clin; 2013 Feb; 31(1):75-87. PubMed ID: 23217689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurally mediated syncope complicated with paroxysmal atrial fibrillation.
    Kato H; Masutani S; Hoshiyama M; Shibuya K; Isoda T; Hishi T; Murakawa Y; Yanagisawa M
    Acta Paediatr Jpn; 1996 Dec; 38(6):695-8. PubMed ID: 9002313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysautonomia and neurocardiogenic syncope.
    McLeod KA
    Curr Opin Cardiol; 2001 Mar; 16(2):92-6. PubMed ID: 11224639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of atropine in vasovagal syncope induced by head-up tilt testing.
    Santini M; Ammirati F; Colivicchi F; Gentilucci G; Guido V
    Eur Heart J; 1999 Dec; 20(23):1745-51. PubMed ID: 10562483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of propranolol to prevent tilt-evoked systemic vasodilatation, adrenaline release and neurocardiogenic syncope.
    Eldadah BA; Pechnik SL; Holmes CS; Moak JP; Saleem AM; Goldstein DS
    Clin Sci (Lond); 2006 Sep; 111(3):209-16. PubMed ID: 16634720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study.
    Kaufmann H; Saadia D; Voustianiouk A
    Ann Neurol; 2002 Sep; 52(3):342-5. PubMed ID: 12205647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.